3:
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.
Colombo S, Rauch A, Rotger M, Fellay J, Martinez R, Fux C, Thurnheer C, Günthard HF, Goldstein DB, Furrer H, Telenti A; Swiss HIV Cohort Study.
J Infect Dis. 2008 Sep 15;198(6):864-7.
PMID: 18684101 [PubMed - indexed for MEDLINE]
Related Articles
5:
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
Young B, Squires K, Patel P, Dejesus E, Bellos N, Berger D, Sutherland-Phillips DH, Liao Q, Shaefer M, Wannamaker P.
AIDS. 2008 Aug 20;22(13):1673-5.
PMID: 18670229 [PubMed - indexed for MEDLINE]
Related Articles
8:
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J.
Immunity. 2008 Jun;28(6):822-32. Erratum in: Immunity. 2008 Jul;29(1):165.
PMID: 18549801 [PubMed - indexed for MEDLINE]
Related Articles
9:
Abacavir hypersensitivity.
Vandekerckhove L, Blot S, Vogelaers D.
N Engl J Med. 2008 Jun 5;358(23):2514-5; author reply 2515-6. No abstract available.
PMID: 18525052 [PubMed - indexed for MEDLINE]
Related Articles
15:
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
Saag M, Balu R, Phillips E, Brachman P, Martorell C, Burman W, Stancil B, Mosteller M, Brothers C, Wannamaker P, Hughes A, Sutherland-Phillips D, Mallal S, Shaefer M; Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team.
Clin Infect Dis. 2008 Apr 1;46(7):1111-8.
PMID: 18444831 [PubMed - indexed for MEDLINE]
Related Articles